A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients

Donald Chang, Lorraine Liem, Marcio Malogolowkin

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Pharmacokinetics of vancomycin and dosage requirements were evaluated prospectively in 28 pediatric cancer patients 9 months to 13 years of age. The predictive performance of a two- compartment Bayesian forecasting program was also evaluated. A mean (±SD) daily dosage of 75 ± 22 mg/kg/day was necessary to attain a mean peak serum vancomycin concentration (SVC) of 23.1 ± 5.8 mg/liter and a mean trough SVC of 6.2 ± 2.3 mg/liter. Mean vancomycin clearance, volume of distribution and serum half-life were 0.153 ± 0.033 liter/hour/kg, 0.63 ± 0.08 liter/kg and 2.95 ± 0.48 hours. Final peak SVCs, which reflected the last dosage regimens received, were predicted with minimal bias (mean prediction error, -1.2 mg/liter) and accurate precision (root mean- squared prediction error, 2.0 mg/liter) whereas trough SVCs were predicted with even smaller bias (mean prediction error, -0.1 mg/liter) and greater precision (root mean-squared prediction error, 0.8 mg/liter). This study showed that pediatric cancer patients with normal renal function required vancomycin dosage regimens substantially greater than the standard 40 mg/kg/day to attain the desired SVCs.

Original languageEnglish (US)
Pages (from-to)969-974
Number of pages6
JournalPediatric Infectious Disease Journal
Volume13
Issue number11
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Vancomycin
Pharmacokinetics
Prospective Studies
Pediatrics
Neoplasms
Serum
Half-Life
Kidney

Keywords

  • Bayesian pharmacokinetics
  • Cancer patients
  • Pediatric
  • Vancomycin dosage

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients. / Chang, Donald; Liem, Lorraine; Malogolowkin, Marcio.

In: Pediatric Infectious Disease Journal, Vol. 13, No. 11, 01.01.1994, p. 969-974.

Research output: Contribution to journalArticle

@article{8ddfe68cffbe4913a0e00c211460fedf,
title = "A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients",
abstract = "Pharmacokinetics of vancomycin and dosage requirements were evaluated prospectively in 28 pediatric cancer patients 9 months to 13 years of age. The predictive performance of a two- compartment Bayesian forecasting program was also evaluated. A mean (±SD) daily dosage of 75 ± 22 mg/kg/day was necessary to attain a mean peak serum vancomycin concentration (SVC) of 23.1 ± 5.8 mg/liter and a mean trough SVC of 6.2 ± 2.3 mg/liter. Mean vancomycin clearance, volume of distribution and serum half-life were 0.153 ± 0.033 liter/hour/kg, 0.63 ± 0.08 liter/kg and 2.95 ± 0.48 hours. Final peak SVCs, which reflected the last dosage regimens received, were predicted with minimal bias (mean prediction error, -1.2 mg/liter) and accurate precision (root mean- squared prediction error, 2.0 mg/liter) whereas trough SVCs were predicted with even smaller bias (mean prediction error, -0.1 mg/liter) and greater precision (root mean-squared prediction error, 0.8 mg/liter). This study showed that pediatric cancer patients with normal renal function required vancomycin dosage regimens substantially greater than the standard 40 mg/kg/day to attain the desired SVCs.",
keywords = "Bayesian pharmacokinetics, Cancer patients, Pediatric, Vancomycin dosage",
author = "Donald Chang and Lorraine Liem and Marcio Malogolowkin",
year = "1994",
month = "1",
day = "1",
doi = "10.1097/00006454-199411000-00007",
language = "English (US)",
volume = "13",
pages = "969--974",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients

AU - Chang, Donald

AU - Liem, Lorraine

AU - Malogolowkin, Marcio

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Pharmacokinetics of vancomycin and dosage requirements were evaluated prospectively in 28 pediatric cancer patients 9 months to 13 years of age. The predictive performance of a two- compartment Bayesian forecasting program was also evaluated. A mean (±SD) daily dosage of 75 ± 22 mg/kg/day was necessary to attain a mean peak serum vancomycin concentration (SVC) of 23.1 ± 5.8 mg/liter and a mean trough SVC of 6.2 ± 2.3 mg/liter. Mean vancomycin clearance, volume of distribution and serum half-life were 0.153 ± 0.033 liter/hour/kg, 0.63 ± 0.08 liter/kg and 2.95 ± 0.48 hours. Final peak SVCs, which reflected the last dosage regimens received, were predicted with minimal bias (mean prediction error, -1.2 mg/liter) and accurate precision (root mean- squared prediction error, 2.0 mg/liter) whereas trough SVCs were predicted with even smaller bias (mean prediction error, -0.1 mg/liter) and greater precision (root mean-squared prediction error, 0.8 mg/liter). This study showed that pediatric cancer patients with normal renal function required vancomycin dosage regimens substantially greater than the standard 40 mg/kg/day to attain the desired SVCs.

AB - Pharmacokinetics of vancomycin and dosage requirements were evaluated prospectively in 28 pediatric cancer patients 9 months to 13 years of age. The predictive performance of a two- compartment Bayesian forecasting program was also evaluated. A mean (±SD) daily dosage of 75 ± 22 mg/kg/day was necessary to attain a mean peak serum vancomycin concentration (SVC) of 23.1 ± 5.8 mg/liter and a mean trough SVC of 6.2 ± 2.3 mg/liter. Mean vancomycin clearance, volume of distribution and serum half-life were 0.153 ± 0.033 liter/hour/kg, 0.63 ± 0.08 liter/kg and 2.95 ± 0.48 hours. Final peak SVCs, which reflected the last dosage regimens received, were predicted with minimal bias (mean prediction error, -1.2 mg/liter) and accurate precision (root mean- squared prediction error, 2.0 mg/liter) whereas trough SVCs were predicted with even smaller bias (mean prediction error, -0.1 mg/liter) and greater precision (root mean-squared prediction error, 0.8 mg/liter). This study showed that pediatric cancer patients with normal renal function required vancomycin dosage regimens substantially greater than the standard 40 mg/kg/day to attain the desired SVCs.

KW - Bayesian pharmacokinetics

KW - Cancer patients

KW - Pediatric

KW - Vancomycin dosage

UR - http://www.scopus.com/inward/record.url?scp=0028125336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028125336&partnerID=8YFLogxK

U2 - 10.1097/00006454-199411000-00007

DO - 10.1097/00006454-199411000-00007

M3 - Article

VL - 13

SP - 969

EP - 974

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -